The Scientist

» drug development, evolution and immunology

Most Recent

image: Do Microbes Trigger Alzheimer’s Disease?

Do Microbes Trigger Alzheimer’s Disease?

By | September 1, 2017

The once fringe idea is gaining traction among the scientific community.

6 Comments

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

0 Comments

image: Global Patterns of Human Epigenetic Variation

Global Patterns of Human Epigenetic Variation

By | August 28, 2017

A study of five far-flung human populations gives clues to adaptations to environmental pressures.

5 Comments

image: Dengue Infection Impairs Immune Defense Against Zika

Dengue Infection Impairs Immune Defense Against Zika

By | August 18, 2017

A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.

0 Comments

image: Tiny Motors Deliver Ulcer Medication in Mouse Stomachs

Tiny Motors Deliver Ulcer Medication in Mouse Stomachs

By | August 17, 2017

The mini machines treated infection somewhat better than antibiotics plus the typical proton pump inhibitor medication. 

0 Comments

image: Pollution Drives Marine Reptile Color Change

Pollution Drives Marine Reptile Color Change

By | August 11, 2017

The turtle-headed sea snake is losing its stripes, and researchers suggest that the change reflects adaptation to fouled oceans.

1 Comment

image: CRISPR Corrects RNA-based Disease Defects

CRISPR Corrects RNA-based Disease Defects

By | August 10, 2017

In human cells, researchers deploy the genome editor to snip out toxic repetitive sequences.

0 Comments

image: The Ever-Expanding T-Cell World: A Primer

The Ever-Expanding T-Cell World: A Primer

By | August 7, 2017

Researchers continue to identify new T-cell subtypes—and devise ways to use them to fight cancer. The Scientist attempts to catalog them all.

2 Comments

image: Chemogenetics Doesn’t Work Like Many Thought

Chemogenetics Doesn’t Work Like Many Thought

By | August 4, 2017

A study finds the so-called DREADD method of manipulating neurons using a drug called CNO actually works via clozapine.

0 Comments

image: Right-to-Try Bill Passes the Senate

Right-to-Try Bill Passes the Senate

By | August 4, 2017

The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Judge Recommends Ruling to Block Internet Access to Sci-Hub
  3. Opinion: Microbiology Needs More Math
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech